» Articles » PMID: 33177838

Hsa_circ_0006916 Knockdown Represses the Development of Hepatocellular Carcinoma Via Modulating MiR-599/SRSF2 Axis

Overview
Publisher Dove Medical Press
Specialty Oncology
Date 2020 Nov 12
PMID 33177838
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aberrantly expressed circular RNAs (circRNAs) are implicated in the progression of hepatocellular carcinoma (HCC). CircRNA hsa_circ_0006916 (circ_0006916) is dysregulated in HCC, but the function and mechanism of this circRNA in HCC development remain uncertain.

Methods: Thirty paired HCC and normal tissues were collected. circ_0006916, microRNA (miR)-599 and serine/arginine rich splicing factor 2 () abundances were examined via quantitative reverse transcription polymerase chain reaction or Western blot. Cell viability, colony ability, migration, invasion, cell cycle and apoptosis were tested via cell counting kit-8, colony formation, wound healing analysis, transwell analysis, and flow cytometry. The interaction between miR-599 and circ_0006916 or was analyzed via dual-luciferase reporter and RNA immunoprecipitation analyses. The function of circ_0006916 on cell growth in vivo was analyzed via xenograft model.

Results: circ_0006916 expression was increased in HCC tissues and cell lines. circ_0006916 knockdown reduced cell viability, colony formation, migration and invasion and caused cell cycle arrest and apoptosis. miR-599 was targeted via circ_0006916, and miR-599 knockdown reversed the influence of circ_0006916 silence on HCC progression. was targeted via miR-599, and miR-599 overexpression suppressed cell viability, colony formation, migration and invasion and promoted cell cycle arrest and apoptosis via decreasing . circ_0006916 could regulate expression via miR-599. circ_0006916 knockdown decreased HCC cell growth in the xenograft model.

Conclusion: circ_0006916 knockdown represses the progression of HCC via regulating miR-599 and .

Citing Articles

Identification of a circRNA-miRNA-mRNA regulatory network for exploring novel therapeutic options for glioma.

He Y, Chen Y, Tong Y, Long W, Liu Q PeerJ. 2021; 9:e11894.

PMID: 34434651 PMC: 8351580. DOI: 10.7717/peerj.11894.


Current Molecular Biology and Therapeutic Strategy Status and Prospects for circRNAs in HBV-Associated Hepatocellular Carcinoma.

Liao R, Liu L, Zhou J, Wei X, Huang P Front Oncol. 2021; 11:697747.

PMID: 34277444 PMC: 8284075. DOI: 10.3389/fonc.2021.697747.

References
1.
Wang P, Guo L, Li K, Ning S, Shi W, Liu Z . Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients. Cancer Biomark. 2017; 21(3):681-687. DOI: 10.3233/CBM-170770. View

2.
Dudekula D, Panda A, Grammatikakis I, De S, Abdelmohsen K, Gorospe M . CircInteractome: A web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2015; 13(1):34-42. PMC: 4829301. DOI: 10.1080/15476286.2015.1128065. View

3.
Dai X, Zhang N, Cheng Y, Yang T, Chen Y, Liu Z . RNA-binding protein trinucleotide repeat-containing 6A regulates the formation of circular RNA circ0006916, with important functions in lung cancer cells. Carcinogenesis. 2018; 39(8):981-992. DOI: 10.1093/carcin/bgy061. View

4.
Ryerson A, Eheman C, Altekruse S, Ward J, Jemal A, Sherman R . Annual Report to the Nation on the Status of Cancer, 1975-2012, featuring the increasing incidence of liver cancer. Cancer. 2016; 122(9):1312-37. PMC: 4840031. DOI: 10.1002/cncr.29936. View

5.
Klingenberg M, Matsuda A, Diederichs S, Patel T . Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets. J Hepatol. 2017; 67(3):603-618. DOI: 10.1016/j.jhep.2017.04.009. View